Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q2 2024 vs. Q1 2024
How the institutions holding Sunshine Biopharma Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 15 | 11 | −4 |
| Shares | 5.72M | 216.6K | −5.51M (−96.2%) |
| Value | $346.2K | $89.6K | −$256.6K (−74.1%) |
New holders (5)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 76,967 | $32.1K | 0.00% |
| Sabby Management, LLC | 20,000 | $8.35K | 0.11% |
| Qube Research & Technologies Ltd | 1,529 | $638 | 0.00% |
| Morgan Stanley | 1,000 | $418 | 0.00% |
| National Bank of Canada | 65 | $26 | 0.00% |
Sold out (9)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Renaissance Technologies LLC | 4,610,900 | $279.0K |
| Citadel Advisors LLC | 550,514 | $33.3K |
| Bridgeway Capital Management, LLC | 286,100 | $17.3K |
| Royal Bank of Canada | 65,000 | $4.00K |
| Geode Capital Management, LLC | 20,179 | $1.22K |
| Two Sigma Investments, LP | 19,196 | $1.16K |
| Federation des caisses Desjardins du Quebec | 79 | $5 |
| Advisor Group Holdings, Inc. | 68 | $4 |
| Rise Advisors, LLC | 18 | $1 |